New Horizon Medical Solutions has announced a strategic collaboration with Soring, the U.S. affiliate of German medical technology company Söring, to distribute ultrasonic wound debridement devices in the United States. The partnership aims to enhance wound care treatment across multiple medical environments by integrating advanced technology with clinical solutions.
The Söring Ultrasonic-Assisted Wound debridement system consists of an ultrasonic generator and instrument designed for debridement and wound cleansing of chronic and acute wounds. The technology can remove fibrin tissues including necroses, fibrin, scab, and pus while breaking up biofilms that impede healing. Clinical applications include treatment of diabetic foot syndrome, decubitus ulcers, burns, post-surgical wounds, and post-traumatic wounds.
Medical experts have noted the potential benefits of integrating this technology with existing wound care approaches. Jeffrey Alan Niezgoda, MD, FACHM, MAPWCA, CHWS, Chief Medical Officer of Kent Imaging and board member of NHMS, stated that using the SONOCA 185 and UAW instruments for ultrasonic wound debridement, when guided by SnapshotGLO and monitored by SnapshotNIR, can significantly improve wound management and lead to better patient outcomes. These devices synergistically optimize wound bed preparation prior to the application of cellular and/or tissue-based products.
Will Hall, CEO of New Horizon Medical Solutions, emphasized the strategic importance of this collaboration, stating that it reflects the company's belief that the future of wound care lies in combining advanced technology with evidence-based clinical solutions. By incorporating Söring's ultrasonic system into their portfolio, NHMS is expanding access to innovative tools that address critical gaps in treatment while improving efficiency and outcomes across care settings. More information about New Horizon Medical Solutions can be found at https://www.nhmedical.com.
The collaboration represents a significant development in advanced wound care technologies, potentially offering healthcare providers more effective tools for managing complex wounds. Söring, founded in 1985 and headquartered in Germany, specializes in ultrasonic tissue resection and ablation technologies used by healthcare professionals worldwide. The company focuses on developing medical technologies that push the boundaries of modern surgery while maintaining a clear emphasis on patient outcomes through intuitive user experience and direct service support.
This partnership between NHMS and Soring could have broader implications for the wound care industry by demonstrating how strategic collaborations can accelerate the adoption of specialized medical technologies. The ultrasonic debridement system addresses several challenges in wound management, particularly the removal of biofilms and necrotic tissue that can impede healing processes. As healthcare systems continue to seek more efficient and effective treatment options for chronic wounds, which represent a significant burden on patients and healthcare resources, technologies like the Söring system may play an increasingly important role in standard care protocols.
